Madrigal Pharmaceuticals Inc (MDGL) — Cash Flow Reinvestment Rate
Madrigal Pharmaceuticals Inc (MDGL) has a Cash Flow Reinvestment Rate of 2.60x as of September 2025, reinvesting $207.85 Million (capex $857.00K plus investments $-207.00 Million) from operating cash flow of $79.85 Million. Explore reinvestment intensity of Madrigal Pharmaceuticals Inc to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Madrigal Pharmaceuticals Inc Cash Flow Reinvestment Rate (2007–2007)
Historical reinvestment intensity for Madrigal Pharmaceuticals Inc across 1 annual periods. Also explore Madrigal Pharmaceuticals Inc (MDGL) total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Madrigal Pharmaceuticals Inc (2007–2007)
Year-by-year capital reinvestment analysis for Madrigal Pharmaceuticals Inc. For live market cap and broader valuation context, see market value of Madrigal Pharmaceuticals Inc.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2007 | 0.09x | $2.35 Million | $27.22 Million | $2.35 Million | — |